Hello and welcome to Slate Money, your guide to the business and finance news of a week that was dominated actually in many ways by a man named RFK Jr, who we're going to talk about in a couple of different contexts on this show.

Do not be put off. It's a fun show.

I am Felix Amon of Bloomberg.

I'm here with Emily Peck of Axios.

Hello, hello.

With Elizabeth Spires of New York Times.

Hello.

And we are going to talk about Tim Cook.

That's the main segment. We need to are going to talk about Tim Cook. That's the main segment.

We need to talk about the legacy of Tim Cook and what he meant for America and for gay

CEOs and for China and for various different things.

He has announced that he is stepping down as CEO, although he is still going to be sticking

around.

We are going to talk about peptides.

This is the first time that RFK Jr. pops up in this show because he wants to make it easier

for compounding pharmacies, make and sell these things that the tech grows and various other people

are very much into, even though there's no real clinical data supporting the claims that are being made for them.

Emily, who's going to join us on that one?

Our special guest, Felix, is Adriel Bettelheim.

He's the senior healthcare editor at Axios.

He is great.

He is going to be joining us from a basement in the capital somewhere.

...